XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Shareholders' and Total Equity - USD ($)
$ in Thousands
Total
Total Precigen Shareholders' Equity
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Noncontrolling Interests
Balances (in shares) at Dec. 31, 2018     160,020,466        
Balances at Dec. 31, 2018 $ 378,722 $ 362,855 $ 0 $ 1,722,012 $ (28,612) $ (1,330,545) $ 15,867
Increase (Decrease) in Stockholders' Equity              
Stock-based compensation expense 9,115 9,046   9,046     69
Shares issued upon vesting of restricted stock units and for exercises of stock options and warrants (in shares)     632,015        
Shares issued upon vesting of restricted stock units and for exercises of stock options and warrants $ 307 57   57     250
Shares issued for accrued compensation (in shares) 150,908            
Shares issued for accrued compensation $ 1,102 1,102   1,102      
Shares issued as payment for services (in shares)     1,114,035        
Shares issued as payment for services 5,688 5,688   5,688      
Shares and warrants issued in public and private offerings, net of issuance costs 6,611           6,611
Deconsolidation of subsidiary (21,672)           (21,672)
Adjustments for noncontrolling interests 0 (456)   (456)     456
Net loss (101,067) (99,475)       (99,475) (1,592)
Release of cumulative foreign currency translation adjustments to loss from discontinued operations 0            
Other comprehensive income (loss) 417 406     406   11
Balances (in shares) at Jun. 30, 2019     161,917,424        
Balances at Jun. 30, 2019 279,223 279,223 $ 0 1,737,449 (28,206) (1,430,020) 0
Balances (in shares) at Mar. 31, 2019     160,615,416        
Balances at Mar. 31, 2019 334,823 313,029 $ 0 1,732,608 (28,325) (1,391,254) 21,794
Increase (Decrease) in Stockholders' Equity              
Stock-based compensation expense 61 56   56     5
Shares issued upon vesting of restricted stock units and for exercises of stock options and warrants (in shares)     345,378        
Shares issued upon vesting of restricted stock units and for exercises of stock options and warrants 0 0   0     0
Shares issued as payment for services (in shares)     956,630        
Shares issued as payment for services 4,857 4,857   4,857      
Deconsolidation of subsidiary (21,672)           (21,672)
Adjustments for noncontrolling interests 0 (72)   (72)     72
Net loss (38,931) (38,766)       (38,766) (165)
Release of cumulative foreign currency translation adjustments to loss from discontinued operations 0            
Other comprehensive income (loss) 85 119     119   (34)
Balances (in shares) at Jun. 30, 2019     161,917,424        
Balances at Jun. 30, 2019 $ 279,223 279,223 $ 0 1,737,449 (28,206) (1,430,020) $ 0
Balances (in shares) at Dec. 31, 2019 163,274,880   163,274,880        
Balances at Dec. 31, 2019   71,711 $ 0 1,752,048 (27,468) (1,652,869)  
Increase (Decrease) in Stockholders' Equity              
Stock-based compensation expense   9,269   9,269      
Shares issued upon vesting of restricted stock units and for exercises of stock options and warrants (in shares)     840,468        
Shares issued upon vesting of restricted stock units and for exercises of stock options and warrants   66   66      
Shares issued for accrued compensation (in shares)     1,805,405        
Shares issued for accrued compensation   5,100   5,100      
Shares issued as payment for services (in shares)     392,483        
Shares issued as payment for services   930   930      
Shares issued in private placement (in shares)     5,972,696        
Shares and warrants issued in public and private offerings, net of issuance costs   35,000   35,000      
Net loss $ (99,352) (99,352)       (99,352)  
Release of cumulative foreign currency translation adjustments to loss from discontinued operations $ 26,957 26,957     26,957    
Other comprehensive income (loss)   (139)     (139)    
Balances (in shares) at Jun. 30, 2020 172,285,932   172,285,932        
Balances at Jun. 30, 2020   49,542 $ 0 1,802,413 (650) (1,752,221)  
Balances (in shares) at Mar. 31, 2020     170,656,834        
Balances at Mar. 31, 2020   87,229 $ 0 1,797,450 (1,354) (1,708,867)  
Increase (Decrease) in Stockholders' Equity              
Stock-based compensation expense   4,897   4,897      
Shares issued upon vesting of restricted stock units and for exercises of stock options and warrants (in shares)     171,682        
Shares issued upon vesting of restricted stock units and for exercises of stock options and warrants   66   66      
Shares issued for accrued compensation (in shares)     1,457,416        
Shares issued for accrued compensation   0   0      
Net loss $ (43,354) (43,354)       (43,354)  
Release of cumulative foreign currency translation adjustments to loss from discontinued operations $ 0            
Other comprehensive income (loss)   704     704    
Balances (in shares) at Jun. 30, 2020 172,285,932   172,285,932        
Balances at Jun. 30, 2020   $ 49,542 $ 0 $ 1,802,413 $ (650) $ (1,752,221)